Linde India Ltd
Linde India Ltd Q1 FY26 Results & Presentation Highlights: Revenue, Margins & Order Book
Q1 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on Linde India Ltd's Q1 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million. - Gases division revenue grew modestly by 2% (+402 million INR) despite challenging economic environment. - Project Engineering Division (PED) revenue declined sharply by 42.1% (–3,235 million INR) due to project cycle. - Gases revenue for FY25 rose by 2% driven by strong gas demand and pricing discipline. - EBITDA improved by 6.9%, with Gases EBITDA up 8.5% and PED EBITDA down 3.8%. - Volume specifics mention approx. EBITDA for FY 2024-25: ₹8,329 million, a 6.9% increase YoY from ₹7,793 million - EBITDA Margin improved by 536 basis points from 28.1% in FY 2023-24 to 33.5% in FY 2024-25 - Profit After Tax (PAT)
From Linde India Ltd's Q1 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million.
- Gases division revenue grew modestly by 2% (+402 million INR) despite challenging economic environment.
- Project Engineering Division (PED) revenue declined sharply by 42.1% (–3,235 million INR) due to project cycle.
- Gases revenue for FY25 rose by 2% driven by strong gas demand and pricing discipline.
- EBITDA improved by 6.9%, with Gases EBITDA up 8.5% and PED EBITDA down 3.8%.
- Volume specifics mention approx. 20 lakh m³ compressed gases per month and >300 tonnes medical oxygen delivered daily.
- Outlook: Industrial gases market expected to grow at +7% CAGR (2025-2030).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Linde India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Multiple capex projects under construction supporting growth; exact amounts not specified (Page 15)
- Self-financing for strategic investments in growth capex projects (Page 10)
- Rooftop solar projects at Jamshedpur & Pune PGP underway, totaling 914 KWp across 8 sites including Uluberia (Page 18)
- Renewable energy sourcing at 155 GWh (+14% YoY) in FY25 achieving 13% grid power replacement (Page 18)
- Renewable energy contracted for 425 MUs for Tata KPO to start in 2026 (Page 18)
- On track for 35% GHG emission reduction by 2035, with fleet management & electric forklifts deployed at select sites (Page 18)
- Expansion of Zero Waste Program to cover all operation sites except 3rd party sites (Page 18)
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Linde India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Linde India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹701 Cr, net profit ₹192 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Linde India Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Balaji Amines Ltd (Q1 FY26)
Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25…
- Vidhi Specialty Food Ingredients Ltd (Q1 FY26)
87.9 Crores . Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY26 investor presentation — and how it ranks against sector pe
- Chemcon Speciality Chemicals Ltd (Q1 FY26)
Q1 FY26 revenue from operations: ₹53.5 Cr, up 18% YoY from ₹45.5 Cr in Q1 FY25 (Page 7 & 6). Key investor presentation takeaways from Chemcon Speciality Chemica
- Valiant Organics Ltd (Q1 FY26)
FY22: INR 1,153 Cr . Key investor presentation takeaways from Valiant Organics Ltd's Q1 FY26 investor presentation — and how it ranks against sector peers.
Frequently Asked Questions
What were Linde India Ltd Q1 FY26 results?
Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million. - Gases division revenue grew modestly by 2% (+402 million INR) despite challenging economic environment. - Project Engineering Division (PED) revenue declined sharply by 42.1% (–3,235 million INR) due to project cycle. - Gases revenue for FY25 rose by 2% driven by strong gas demand and pricing discipline. - EBITDA improved by 6.9%, with Gases EBITDA up 8.5% and PED EBITDA down 3.8%. - Volume specifics mention approx. EBITDA for FY 2024-25: ₹8,329 million, a 6.9% increase YoY from ₹7,793 million - EBITDA Margin improved by 536 basis points from 28.1% in FY 2023-24 to 33.5% in FY 2024-25 - Profit After Tax (PAT)
What is Linde India Ltd share price analysis?
Linde India Ltd currently shows a neutral. The stock trades at a P/E of 97.0 with a market cap of ₹53,228 Cr. Investors should review the full earnings analysis for detailed insights.
Is Linde India Ltd planning capital expenditure?
Multiple capex projects under construction supporting growth; exact amounts not specified (Page 15) - Self-financing for strategic investments in growth capex projects (Page 10) - Rooftop solar pr
Keep Linde India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.